Sign up for the QMED & MD+DI Daily newsletter.
Covidien, BMS Sell Off Units
In efforts to focus on their core competencies, one device giant has sold of its retail business, and one pharmaceutical giant has sold off a device business. Covidien announced that it will sell its retail business to First Quality Enterprises, Inc. for about $335 million. The unit includes infant care, feminine hygiene, and adult incontinence products.
December 17, 2007
1 Min Read
.svg?width=1280&auto=webp&quality=95&format=jpg&disable=upscale "MDDI")
Likewise, drugmaker Bristol-Myers Squibb will sell its medical imaging unit to private equity firm Avista Capital Partners for about $525 million. Avista is the same firm that bought Boston Scientific's fluid management and venous access businesses last week for $425 million.
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)